Singapore markets open in 6 hours 2 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,300.34 +53.66 (+1.02%) Dow
39,832.17 +274.06 (+0.69%) Nasdaq
16,728.00 +216.82 (+1.31%) Bitcoin USD
65,507.65 +4,119.00 (+6.71%) CMC Crypto 200
1,380.97 +113.02 (+8.91%)
PCVX May 2024 65.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:59PM EDT. Market open.
| Previous close | 3.7500 |
| Open | 3.3000 |
| Bid | 3.5000 |
| Ask | 8.0000 |
| Strike | 65.00 |
| Expiry date | 2024-05-17 |
| Day's range | 3.3000 - 3.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | 497 |
- GuruFocus.com
Vaxcyte Inc (PCVX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Overview
Consistent with Analyst Projections Amidst Strategic Advancements
GlobeNewswireVaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
-- VAX-31 Adult Phase 1/2 Study Enrollment Completed; Topline Safety, Tolerability and Immunogenicity Data Expected in Third Quarter of 2024 -- -- Following VAX-31 Adult Phase 1/2 Study Readout, Vaxcyte to Advance VAX-24 or VAX-31 to Adult Phase 3 Program -- -- VAX-24 Infant Phase 2 Study Enrollment Completed; Topline Data from Primary Immunization Series Expected by End of First Quarter of 2025, Followed by Topline Data from Booster Dose by End of 2025 -- -- $1.9 Billion in Cash, Cash Equivalen
GuruFocus.comInsider Sale at Vaxcyte Inc: COO Jim Wassil Sells 3,000 Shares
On May 1, 2024, Jim Wassil, the Chief Operating Officer of Vaxcyte Inc (NASDAQ:PCVX), sold 3,000 shares of the company.
© 2024 Yahoo. All rights reserved.